altRX vs Näky
Näky costs $4 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between altRX and Näky, the first difference is cost: Näky is $4 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. altRX leads our six-part score, 7.6 to 6.3. One of the two has an FDA warning letter on record, covered below.
altRX vs Näky price
Näky is the cheaper way in: $145 a month against $149 a month at altRX. That is $4 less each month (3% lower), or about $48 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Näky ($145 a month vs $149 a month); tirzepatide is cheaper at altRX ($249 a month vs $295 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
altRX lists 50 states, and Näky does not publish where it ships.
Pricing
altRX
Näky
What each price covers
Both prices cover shipping.
altRX's price also covers the clinician visit and the medication itself, which Näky does not claim.
altRX is silent on lab work and coaching.
Näky is silent on the clinician visit, the medication itself, lab work and coaching.
That matters most for the drug: unless Näky confirms otherwise, budget for medication on top of its listed price.
altRX
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Näky
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, altRX scores 7.6 and Näky 6.3 out of 10.
altRX is stronger on user experience (8.0 vs 3.0), trust & safety (6.0 vs 4.0), accessibility (10.0 vs 5.0) and support (7.0 vs 5.0).
Näky is stronger on value (6.8 vs 5.0).
Effectiveness is within half a point.
altRX
7.6/10
Näky
6.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.
Näky has no FDA warning letter on record with us.
Features & Coverage
| Feature | altRX | Näky |
|---|---|---|
| Starting Price | $149/mo | ✓$145/mo |
| Features | 8 features | 8 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About altRX
Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.
Read our full altRX review →About Näky
Pricing at steady state stays behind the intake. Näky holds LegitScript approval and sells compounded semaglutide and compounded tirzepatide, adds an oral semaglutide drops product that few others carry, runs a GLP-1 microdose program separately, and offers NAD+ and Sermorelin on top. Getting started means a 3-minute assessment online, after which a licensed provider returns a treatment plan the same day. For the oral line a NAKY10 promo code is referenced.
Read our full Näky review →Pros & Cons
altRX
What we like
- Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Semaglutide costs $1149 a month, 15% above the $997 median for brand-name semaglutide across the sellers we compare
- The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Näky
What we like
- Semaglutide costs $145 a month, 22% below the $185 median for compounded semaglutide across the sellers we compare
- The monthly price stays the same as your dose goes up
- The monthly price includes shipping
- We found no FDA warning letters issued to Näky
Watch-outs
- Tirzepatide costs $295 a month, 18% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
altRX wins this one, 7.6 to 6.3, above all for semaglutide from $1149/month. Näky undercuts it by $4 a month, so if the monthly bill is what decides it, Näky is the pick.
Choose altRX if…
You want semaglutide from $1149/month and an opening price near $149 a month.
Choose Näky if…
You want the lower starting price and an opening price near $145 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →altRX vs Näky: FAQ
Close alternatives to altRX and Näky
- altRX vs Gala
- altRX vs Sprout Health
- altRX vs Aquivia Health
- altRX vs Vytora Health
- Näky vs Gala
- Näky vs Sprout Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.